Gilead Oncology Grant Supports 22 U.S. Organizations With $3.15 Million to Provide Support to Those Affected By Breast Cancer

Oct 31, 2024 9:15 AM ET

"As a community leader, my goal is to reduce health disparities. We have to share information. We have to share the resources out there."

We're prioritizing health equity for patients across the cancer care continuum. Our Gilead Oncology Grant supports 22 U.S. organizations with $3.15 million to provide resources for people affected by breast cancer. Learn more here: https://gilead.inc/3NM4Vmo

Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives to transform and simplify care for people with life-threatening illnesses around the world. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California.

Originally published by Gilead Sciences

Gilead Oncology Grant Supports 22 U.S. Organizations With $3.15 Million to Provide Support to Those Affected By Breast Cancer

More from Gilead Sciences

Gilead Sciences: Designing Inclusive Clinical Trials in an Effort To Upend the HIV Epidemic

Gilead Helps Pen a Children’s Book for Families Facing Breast Cancer

Gilead Foundation’s Healthcare Education, Access and Leadership (HEAL) Initiative Is Dedicating $5 Million to Help Build a More Diverse Bay Area Healthcare Workforce

Gilead Sciences: New Report Shows Every Country in the World Must Do More To End the HIV Epidemic

Championing HIV Services for LGBTQ+ Youth

Working to Build Next-Generation Cancer Therapies

Helping End HIV - Gilead Sciences

Seramount Ranks Gilead Sciences Among Its Leading Inclusion Index Company